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ABSTRACT
The MMR – maternal mortality ratio – has risen from obscurity to become 
a major global health indicator, even appearing as an indicator of progress 
towards the global Sustainable Development Goals. This has happened 
despite intractable challenges relating to the measurement of maternal 
mortality. Even after three decades of measurement innovation, maternal 
mortality data are widely presumed to be of poor quality, or, as one leading 
measurement expert has put it, ‘guilty until proven innocent’. This paper 
explores how and why leading epidemiologists, demographers and 
statisticians have devoted the better part of the last three decades to 
producing ever more sophisticated and expensive surveys and mathematical 
models of globally comparable MMR estimates. The development of better 
metrics is publicly justified by the need to know which interventions save lives 
and at what cost. We show, however, that measurement experts’ work has 
also been driven by the need to secure political priority for safe motherhood 
and by donors’ need to justify and monitor the results of investment flows. 
We explore the many effects and consequences of this measurement work, 
including the eclipsing of attention to strengthening much-needed national 
health information systems. We analyse this measurement work in relation 
to broader political and economic changes affecting the global health field, 
not least the incursion of neoliberal, business-oriented donors such as the 
World Bank and the Bill and Melinda Gates Foundation whose institutional 
structures have introduced new forms of administrative oversight and 
accountability that depend on indicators.
Introduction
The maternal mortality ratio (MMR) has risen from obscurity to become a major global health indicator. 
A measure of the number of women dying of pregnancy-related causes per 100,000 live births, the 
MMR indicates the population-level risk of maternal death. It is also widely regarded as an indicator of 
health system functioning because improving maternal survival depends on a health system that is 
able to refer women to and deliver high-skilled emergency care. More recently, the MMR has achieved 
prominence as an indicator of progress towards global development goals, including the Millennium 
Development Goals (MDGs) and the Sustainable Development Goals that have replaced them (Fukuda-
Parr, Yamin, & Greenstein, 2014). But while MMR estimates have helped to secure a place for maternal 
survival on the global policy agenda (Smith & Rodriguez, 2015), the maternal health field has also 
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struggled to contend with persistent measurement challenges. According to a prominent UK-based 
epidemiologist we interviewed, measurement problems related to the MMR have been a ‘thorn in the 
side of the MDG agenda’ and even after decades of measurement innovation, one expert told us that 
maternal mortality data are widely presumed ‘guilty until proven innocent’ (Storeng & Béhague, 2014).
This paper aims to examine the development of the MMR and the various contestations and practices 
that professionals have engaged in as they chart out what the MMR actually reveals, obscures and does. 
As responsibility for the production and analysis of data has, at least partially, shifted from national 
Ministries of Health to ‘global’ institutions and scientists (Harper, 2006; Rees, 2014), it becomes important 
to examine the roles, perspectives and practices of such scientists and their professional communities. 
In ‘studying up’ (Nader, 1972), we explore how demographers, statisticians and epidemiologists, active 
in international efforts to improve maternal health in low- and middle-income countries, are charged 
with making the numbers appear robust, and indeed ‘innocent’.
We now live in an era in which metrics have been embraced as central to the solution of intracta-
ble global health problems (Adams, 2016b). It is thus not surprising that the international Task Force 
on Child Health and Maternal Health (2005, p. 78) more than a decade ago claimed that ‘the analysis 
of maternal mortality, the range of possible solutions, and the need for priority setting begins with 
numbers’. Advocates of this position often argue that statistical indicators, rankings and monitoring 
are central to the functioning of the various public–private partnerships that have formed in the past 
15 years, including the Partnership for Maternal, Newborn and Child Health. Measurement underlies 
‘greater commitments to transparency and accountability’ and allows ‘better understanding of what 
works: how many lives have been saved and at what cost’ (Boerma & Abou-Zahr, 2007, p. 718).
We argue that an equally important driver of the emphasis on maternal mortality measurement is 
experts’ perceived need to respond to donors’ demand for data to justify and monitor the results of 
investment flows, and to produce data that can help secure – and sustain – global-level political priority 
for safe motherhood in an increasingly competitive policy space (Storeng & Béhague, 2014). While being 
cognisant of the dangers of invoking the term neoliberalism in public health critique (Bell & Green, 
2016), it is clear that measurement experts’ work is increasingly linked to what Adams (2016a, p. 45) 
has recently called the ‘micropractices of neoliberalism’. These practices are ‘not necessarily designed 
with neoliberal outcomes in mind’, but they ‘work seamlessly with the political aspirations of neoliberal 
reforms’ (Adams 2016a, p. 45).
In our analysis, we use the term ‘neoliberal’ to refer quite specifically to the assumption that health 
care priorities setting should be shaped primarily by cost-effectiveness logics and business management 
models. This assumption has become mainstream in the past two decades as part of the transition from 
international, intergovernmental health collaboration to ‘global health’, characterised by market-driven 
approaches and public–private partnerships for health (Birn, Nervi, & Siqueira, 2016). These develop-
ments have been enabled in large part by the rise of neoliberal and business-oriented institutions 
like the World Bank and the Bill & Melinda Gates Foundation as key authorities within global health 
governance (Brown, Cueto, & Fee, 2006; Fee, Cueto, & Brown, 2008). These actors’ institutional practices 
have introduced new forms of administrative oversight, audit and accountability, a clear manifestation 
of the incursion of corporate thinking and culture into broader social spheres (Merry, 2011). As Erikson 
(2015) has shown, today’s dominant global health actors tie market interests to health outcomes in 
ways that depend on numerical indicators. The growing power of private foundations in global health 
governance has also supported the proliferation of competing ‘advocacy coalitions’ and issue-specific 
global health networks (Shiffman et al., 2016), whose success is increasingly defined by their ability to 
reach concrete goals through management-style performance accountability measures that depend 
on health data. This form of accountability provides a stark contrast to the broader social justice goals 
that defined success in earlier stages of the history of international health (Birn, 2009).
We aim to show how these assumptions have influenced the heart of scientific practice, encourag-
ing measurement scientists to accommodate donors’ need for indicators to monitor investment flows, 
ensure financial accountability and justify their claims that they are saving lives. Although measurement 
experts are motivated by broader concerns to advance science and to strengthen national and local 
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health systems, such aims sometimes become subservient to donors’ and international agencies’ needs 
for ‘global’ accountability data. Most notably, the imperative to respond to donors’ data demands has 
encouraged the development of ever more sophisticated and expensive surveys and mathematical 
models to provide globally comparable estimates of maternal mortality that serve to make messy 
numbers appear robust, but that eclipse the building up of much needed national health information 
systems.
What tensions do measurement experts themselves experience over the use of the MMR as the 
key indicator by which progress towards improved maternal health – and towards various politically 
important targets – is assessed? In what follows, we show that despite the consensus that making 
MMR data credible is critical for advocacy, measurement experts sometimes downplay the uncertain-
ties of the MMR out of fear that these uncertainties will lead donors to invest elsewhere. Yet privately, 
they criticise, and sometimes resist, the ways the MMR is used and the donor demands for data that 
make the MMR so central relative to both other numerical indicators and broader forms of evidence. 
We examine how measurement experts become involved in controversies over the numbers that are 
not just technical in nature, but that reveal deep-seated power struggles and ideological differences, 
such as those between international public agencies like the WHO and private donors like the Gates 
Foundation. We highlight the ways that different donors impact on how – and what kinds of – data 
hold sway. At stake, then, is not just the meaning of the numbers, but how to make them meaningful 
(as evidence of success) to the people who matter. Ironically, the people who matter are not the women 
who benefit from maternal health interventions, but the donors who fund them.
Methodology
Our analysis forms part of a broader ethnographic project on the international safe motherhood 
movement and its responses to the rise of evidence-based policy-making (Béhague & Storeng, 2008; 
Béhague & Storeng, 2013; Storeng & Béhague, 2014). To understand the making of the MMR, we draw 
on participant observation over the past decade within research communities, primarily in the UK, and 
at policy events. Our ethnographic access was facilitated by our involvement in an interdisciplinary 
Research Programme Consortium on Maternal and Newborn Health funded by the UK Department 
for International Development and Immpact, a major research initiative on maternal mortality meas-
urement. We also conducted in-depth interviews between 2004 and 2009 with 72 informants from 
multilateral agencies, academic institutions, professional bodies and international non-governmental 
organisations, primarily at the global level. This paper is based largely on interviews with the 23 inform-
ants who were international academic researchers. This epistemic community consisted primarily of 
measurement experts (epidemiologists, statisticians and demographers, many with a clinical back-
ground) based at elite global health research institutes and universities in Europe and North America. 
To understand the evolving debates about maternal mortality measurement, we also draw on histor-
ical and contemporary policy documents and scientific literature and oral histories collected during 
in-depth interviews.
Measurement bottlenecks
‘Sound estimates based on new data … are the foundation of our current understanding and concern,’ 
said WHO’s Director General Halfdan Mahler when addressing the Nairobi conference that launched 
the international Safe Motherhood Initiative (SMI) in 1987 (Mahler, cited in AbouZahr, 2003). Mahler 
was referring to the first global maternal mortality estimates published by the WHO in 1986, showing 
that around 500,000 women were dying annually from causes relating to pregnancy and childbirth, 
99% of them in poor countries (WHO, 1986).
In reality, however, these estimates were not ‘sound’ because most low- and middle-income countries 
lacked reliable systems for registering births and deaths, while many others could not produce statistics 
on mortality by age, sex and cause of death, which are considered basic indicators for understanding 
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a country’s public health profile. The dearth of data in the poorer countries was in stark contrast to 
high-income countries. In such countries, civil registration systems, parish registers and recording of 
maternal deaths in maternity services had enabled analyses of trends in maternal mortality since the 
nineteenth century (Loudon, 1992), and have been considered essential to these countries’ ability to 
dramatically reduce maternal mortality (Béhague & Storeng, 2013). In the absence of empirical meas-
urement in poor countries, the WHO used approximation methods to create the estimates, for instance 
adjusting the deaths to women of reproductive age by the proportion estimated to be due to maternal 
causes – often assumed to be 25–33% (AbouZahr, 1998).
From the late 1980s, academics from leading public health schools such as the London School of 
Hygiene and Tropical Medicine in the UK and Johns Hopkins and Columbia University in the US collab-
orated with WHO statisticians to develop new approaches to estimating maternal mortality. These were 
intended as interim solutions until countries developed functioning vital registration systems capable 
of capturing cause-of-death data. In line with wider developments in the production of health and vital 
statistics, such as the USAID-funded Demographic and Health Surveys, epidemiologists, demographers 
and statisticians at these British and American universities worked on methods to document maternal 
deaths as they occurred in the whole population, including among those women who delivered at 
home. The best known of these, developed by a team led by British epidemiologist Wendy Graham, 
was known as the sisterhood method, an indirect method for estimating maternal mortality based on 
asking adults during a census or survey about deaths during pregnancy and childbirth among their 
adult sisters (Graham, Brass, & Snow, 1989).
These methodological innovations were driven by a belief in what Graham and her colleague Oona 
Campbell referred to as a ‘measurement trap’ (Graham & Campbell, 1992). The measurement trap stip-
ulated that lack of data to establish the levels and trends of specific maternal health outcomes, to 
identify the characteristics and determinants of these outcomes, and to monitor and evaluate the 
effectiveness of programmes, was leading to neglect of maternal health in research and programmes 
in a self-reinforcing cycle. This idea of the ‘measurement trap’ became a key trope in the SMI’s historical 
self-narrative. As one of the initiative’s founding members explained:
It was always measurement. That was always the focus. It was always the belief that part of the problem was in 
measurement bottlenecks and generally feeling that by improving indicators and measurement techniques that 
we would help to address part of the problem. So the problem was neglected because there wasn’t enough infor-
mation, there wasn’t enough information so it was all a vicious circle.
However, experts explained that measurement challenges specific to maternal mortality in low-in-
come countries had hampered attempts to break this ‘vicious cycle’. The classification of maternal mortal-
ity, a widespread tendency to underreport maternal causes in cause-of-death surveys and poor quality 
of available data sources had made it difficult to produce accurate numbers (Campbell & Graham, 1990). 
Moreover, collecting maternal mortality data through surveys was both labour-intensive and expensive, 
because maternal deaths are relatively infrequent at a population level, thus requiring large sample 
sizes to achieve statistical precision (Merdad, Hill, & Graham, 2013). In the Safe Motherhood Initiative’s 
early years, experts debated whether the cost was justified. As Graham has recalled, many came to feel 
that measuring maternal mortality using surveys ‘was pretty much impossible and definitely not an 
efficient use of scarce resources’ (Graham, 2002:701). During this period, many leading epidemiologists 
therefore also worked on developing indicators that could serve as proxies for maternal mortality. For 
example, many worked on developing indicators of severe obstetric morbidity, since such morbidity had 
been shown to occur much more frequently than maternal deaths and was therefore easier to meas-
ure. Others developed process indicators to assess the provision of and women’s access to emergency 
obstetric care services, necessary for treating obstetric complications such as haemorrhage, sepsis and 
obstructed labour, which had been identified as the main direct causes of maternal deaths (Maine, 1991).
Although there was a strong focus on maternal mortality in these early measurement efforts, many 
attempted to keep multiple agendas on the table. The same epidemiologists who led the maternal 
mortality measurement agenda also argued that the focus on mortality was too narrow. Graham and 
Campbell (1992, p. 967), for example, claimed that efforts to dismantle the measurement trap ‘revealed 
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a weak conceptual framework to lie at the very centre’. ‘Maternal health,’ they noted, ‘has tended to 
be conceptualised as a discrete, negative state, characterised by physical rather than social or mental 
manifestations, and by a narrow time-perspective focusing on pregnancy, delivery and the puerperium’ 
(Graham & Campbell, 1992, p. 967). Given these limitations, they called for a broader perspective and 
broader indicators of women’s reproductive health beyond pregnancy.
From measurement for local government to measurement for global accountability
Despite such calls for a broader approach to maternal health indicators, in the second decade of the 
SMI, measurement work was increasingly directed more narrowly towards supplying a growing donor-
driven demand for ‘global’ maternal mortality estimates. This reflected the growing preoccupation with 
financial accountability and ensuring cost-effectiveness during this period. According to informants who 
worked within the field at this time, UN agencies were committed to publishing new global maternal 
mortality estimates every five years, both because governments wanted estimates to justify their claims 
for donor support and because international donors required mortality data as evidence of the impact 
their support was having on saving lives.
The move towards regular monitoring was initiated largely by the World Bank, which, in the early 
1990s, staged what historians have depicted as an aggressive assault on the WHO’s authority within 
international health (Fee et al., 2008). Its Investing in Health report, published in 1993, mainstreamed 
the idea that governments and donors should prioritise selective cost-effective health interventions 
targeting high burden health problems, leaving the rest to the private sector (World Bank, 1993). Cost-
effectiveness was to be assessed using the DALY (disability adjusted life year), a new metric created 
to quantify the overall disease burden from specific health conditions on a global scale, expressed in 
number of years lost due to ill health (Murray & Acharya, 1997). The use of cost-effectiveness analysis to 
guide priority setting was buttressed by the expansion of evidence-based policy-making to countries 
receiving aid, notably the use of randomisation in controlled trials to evaluate clinical effectiveness 
(Dobrow, Goel, & Upshur, 2004; Lambert, 2006).
The rise of new private donors around the turn of the Millennium, most notably the Gates Foundation, 
further entrenched the idea that investments in health should provide ‘value for money’ (Birn, 2014; 
McCoy & McGoey, 2011). From its establishment in 1999, the Gates Foundation quickly became a domi-
nant actor in global health, influencing the behaviour of other donors too. It oversaw the establishment 
of major global public–private partnerships for health, notably GAVI, the Vaccine Alliance and the Global 
Fund, oriented towards the achievement of global goals for child survival and HIV/Aids, TB and Malaria, 
respectively (Brown et al., 2006). Within a few years, nearly 100 public–private partnerships or global 
health initiatives had formed, competing with each other for donor resources, while donor-dependent 
governments competed for grants and other investments from these new actors (Buse & Harmer, 2007).
Maternal health experts we spoke with noted how swiftly both public and private donors adopted an 
emphasis on ‘value for money’ as the ultimate measure of an intervention’s worth. As one USAID-funded 
NGO representative said in an interview in Washington, D.C. in 2005, ‘donors never wanted indicators 
and then they wanted results and everybody started asking “what are you using your money for”... they 
want to see exactly “how many lives my $500,000 has saved.” How many maternal lives were saved?’ 
This preoccupation also reflected intense emphasis on monitoring progress towards the MDGs, itself 
justified in terms of the need for accountability and transparency.
The measurement trap and the competition for political priority
The maternal health field – from policy-makers, to advocacy specialists, to academic researchers – 
 struggled to respond to the exigencies of this hypercompetitive, results-oriented environment. Despite 
the methodological innovations in maternal mortality estimation of the 1990s, by 2004, the WHO (2004) 
noted that ‘problems of underreporting and misclassification are endemic to all (these) methods’. The 
UN’s global estimates continued to be based on regression models or approximation methods rather 
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than ‘real’ measures, because most countries with high levels of maternal mortality did not have a 
reliable system of civil registration (WHO, 2004). Population-based surveys using techniques such as 
the sisterhood method were the dominant data source, but produced estimates that were imprecise 
(subject to wide margins of uncertainty) as a result of sample size issues, making it difficult to provide 
firm statements about global maternal mortality trends (WHO, UNICEF, & UNFPA, 2004, p. 4). With global 
estimates stubbornly stagnant at around 500,000 deaths annually, measurement experts like WHO’s 
Carla AbouZahr (2001, p. 390) noted that ‘it became increasingly difficult to keep maternal health in 
the public eye when there was nothing new to report’. Even though the inclusion of maternal health 
among the Millennium Development Goals generated political commitment, many of our informants 
worried about how to sustain interest given the difficulties with monitoring progress. As we were told 
more than once: ‘a goal that cannot be measured cannot be monitored or met’.
Given the practical challenges of producing annual maternal mortality estimates, a new indicator, 
‘skilled birth attendance’ – deliveries attended by a health worker with midwifery skills – was introduced 
as a proxy indicator for measuring global progress towards the MDGs. But there were measurement 
challenges associated with this indicator too, not least related to the fact that the category of health 
worker classified as ‘skilled’ varies widely across settings. Moreover, key actors questioned the assump-
tion that institutionalising deliveries in settings with high levels of home births would reduce mortality, 
without concomitant changes to the quality of care and acceptability of services offered (see Austveg, 
2011; Spangler, 2012). Maternal health advocates we spoke with, and measurement experts too, were 
candid that demonstrating change in the skilled birth attendance indicator would not have the same 
political power as demonstrating a reduction in the MMR (see also Austveg, 2011).
The lack of ‘gold standard’ RCT-evidence of the impact of proposed interventions on maternal mor-
tality compounded concerns about how to monitor progress towards global goals (Béhague & Storeng, 
2008). As our informants explained, producing such evidence is prohibitively expensive and logistically 
challenging; because maternal mortality is relatively infrequent on a population basis, huge sample 
sizes are needed to achieve statistical precision. Nevertheless, they explained, donors use the lack of 
such evidence of impact of proposed interventions to place their money elsewhere.
Now or never
With researchers increasingly cognisant of the political importance of mortality data, they quickly recast 
improving maternal mortality measurement as a global priority. Wendy Graham (2002, p. 703) even 
said better measurement was a case of ‘now or never’
We must stop saying this [maternal mortality measurement] cannot be tackled and acknowledge the damage 
caused so far. We must recognise the risks of continuing to neglect the data needed by poor countries to inform 
their allocation of scarce resources, and find the funds, the tools, and the opportunities to meet these needs. We 
must build a sustainable evaluation capacity at the country level and a greater demand for reliable measurement 
of maternal mortality…
The irony that this appeal came from Graham, who, a decade earlier had argued vehemently that 
the MMR was too narrow as an indicator of maternal health, was not lost on our informants. As one 
of Graham’s close colleagues, explained, ‘[We] had co-authored a paper saying that you shouldn’t be 
measuring maternal mortality … And then Wendy came back … going for the argument that people 
really want maternal mortality.’ But, as a senior medical doctor and SMI founder elaborated, this renewed 
emphasis on mortality measurement was a direct response to the Gates Foundation and other donors 
who were ‘reluctant to put money into safe motherhood and sort of asked the question, “do you in fact 
not know what to do and would it be worthwhile investing in helping you to find out what to do?”’ 
Graham had argued, he recalled, that ‘you can only identify what are the effective policies if you can first 
of all measure maternal mortality…first of all we need years of improving measuring and then we will 
test policies.’ She persuaded the Gates Foundation and the British and American international devel-
opment agencies to fund a seven-year research programme called Immpact, the Initiative for Maternal 
Mortality Programme Assessment. Immpact promised to develop new measurement methods ‘in order 
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to strengthen capacity for evidence-based decision-making and rigorous evaluation’ and ‘to determine 
and evaluate cost-effective interventions and strategies for improvement,’ though struggled to deliver 
on this promise given the measurement challenges discussed above (University of Aberdeen, 2016).
During this period, major donors also funded measurement experts to contribute to new global 
accountability mechanisms, notably the Countdown to 2015 for Maternal, Newborn and Child Survival, 
initiated in 2003. This initiative tracked progress towards MDG 4 and 5 on child survival and maternal 
health in 75 ‘priority’ countries. According to some of those who participated, it was premised on the 
idea that such monitoring would incentivise governments and donors to prioritise maternal mortality 
reduction. Many measurement experts were also involved in UN-led efforts to improve the mathematical 
models and approximation methods used for producing global maternal mortality estimates. Through 
involvement in Immpact, the Countdown and similar initiatives, leading measurement experts thus 
became increasingly involved in supplying the methods and data needed to ensure accountability and 
value for money of donor investments.
Academics’ willingness to engage in such practices reflects that many construed the problems with 
the maternal mortality indicators as central drivers of their continued struggle to make maternal health 
a global priority. One informant articulated a common view when she said, ‘a major factor in terms of the 
difficulties with achieving progress, has been the difficulty of measuring it … if you can’t measure it, you 
don’t do it’. This view became mainstream following the 2007 publication of political scientist Jeremy 
Shiffman’s (2007, p. 1370) case study of the generation of political priority for safe motherhood. Shiffman 
argued that attracting political support for maternal mortality had been difficult precisely because of 
the technical difficulties with measuring maternal mortality and documenting progress, compounded 
by the fact that maternal deaths were not as common as those caused by other high-burden problems 
like HIV/AIDS and malaria. His take-home message was that improved maternal mortality measurement 
would be key to generating resources and political attention.
Science and advocacy
With health indicators poised as key instruments of competition and governance, measurement experts 
found themselves under new pressure to participate in more active ways in global-level advocacy and 
policy processes. Often, they were called upon to provide scientific legitimacy to the numbers, where 
their impulse to emphasise the uncertainty associated with maternal mortality estimates came into 
conflict with the pressure to provide unequivocal policy-relevant conclusions. An American epidemiolo-
gist conceded that the ‘quick-winnism of the taskmasters … has pushed a lot of people to simplify their 
message’. Although the measurement limitations specific to maternal mortality are no secret within the 
global health field, measurement experts feared that donors would seize on statistical uncertainty as 
an excuse to divert resources to other global health investments that can more conclusively be shown 
to offer ‘value of money’. Debating scientific uncertainty or alternative interpretations of existing data 
could therefore, some felt, undermine donor commitment to maternal health. As one expert put it: 
‘They say they won’t do anything where there isn’t agreement’.
The production of the Lancet series on maternal health, published in 2006, aptly illustrates academics’ 
increasing confrontation with professionalised global health advocacy. The series intended to present 
the state-of-the-art on maternal health, along with an evidence-based justification for prioritisation 
at a time when the MDG on maternal health was perceived to be lagging. A leading epidemiologist at 
a British public health school recalled her discomfort upon realising, during an editorial meeting she 
participated in, that she was expected to draw much firmer conclusions about global trends than she 
felt comfortable doing on the basis of the existing data:
They wanted us to say ‘look how big the problem is. Countries make no progress, yet we know what works and what 
needs to be done’. That’s what people wanted to hear. They called it ‘evidence-based advocacy’… My feeling is that 
it’s slightly more advocacy than evidence because they want us to say ‘there are so many deaths in the world, it’s 
the indicator with the biggest inequality’ etc., etc., yet the evidence base isn’t there.
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Despite her discomfort, she came out of the meeting feeling ‘enlightened’, she recalled; ‘I understood 
that we can’t continue to make these statements, that “we can’t measure, we can’t do anything”’. Rather, 
she explained, she had realised that she could appeal to decision-makers by using existing data to back 
up more positive messages about the potential for future progress.
Similar tensions came to a head in the controversy that erupted with the publication of revised 
global maternal mortality estimates in 2010. For the first time, these estimates were produced not by 
UN statisticians and their academic counterparts, but by the newly formed Institute for Health Metrics 
and Evaluation in Seattle, funded by the Gates Foundation to scrutinise and revise global health data. 
The Institute was led by Chris Murray, who designed the influential DALY methodology in the 1980s, 
which had been heavily contested by maternal health specialists for disfavouring women (Sundby, 
1999). Statisticians at the Seattle institute assessed levels and trends in maternal mortality for 181 
countries for 1980–2008. They constructed a database from multiple sources, including vital registra-
tion data (where available), censuses, surveys and verbal autopsy studies, and used ‘robust analytical 
methods’ to generate modelling estimates of maternal deaths and the MMR for each year between 1980 
and 2008 (Hogan et al., 2010). Their analysis suggested that the global MMR had actually decreased 
substantially over time, by 1.3% per year since 1990, and that the annual number of maternal deaths 
was now much lower than previously assumed, at around 275,000 rather than 500,000. ‘Substantial, 
albeit varied, progress has been made towards MDG 5’, the Institute’s statisticians concluded (Hogan 
et al., 2010, p. 1609).
If maternal health experts had previously worried that the publication of the same figures year after 
year created donor fatigue, many now worried about the implication of the new assertion about a down-
ward trend. Would it mean that the urgency of addressing maternal health would dissipate? Or create 
complacency about donors’ maternal health efforts? Some worried that attributing MMR reduction to 
donor initiatives legitimated donors’ focus on targeted approaches, rather than broader changes to 
address underlying social and economic determinants of health (cf. McCoy, Jensen, Kranzer, Ferrand, & 
Korenromp, 2013). Significantly, they questioned, as Yamin and Boulanger (2014) have recently done, 
what can actually be asserted with respect to the reported progress in MMRs in specific countries, 
given the serious methodological limitations in how the estimates were produced. What’s more, global 
estimates, others highlighted, mask significant internal social inequities. ‘There is a lot of interest in 
having a success story’, said one British epidemiologist, but the flip side of focusing on global success 
is neglect of the vast disparities in maternal mortality that persist both between and within countries, 
which cannot be captured in the global estimates. As a senior WHO official pointed out, if overall reduc-
tion ‘was achieved by zeroing maternal mortality in the top forty percent by socioeconomic status of 
women of reproductive age and doing nothing for women in the bottom sixty percent … that’s not 
particularly encouraging’.
Significantly, the publication of the new figures also brought to the fore an emerging power struggle 
over who holds the authority to define global data. The fact that the Gates Foundation had funded the 
new estimates was widely perceived as a direct assault on WHO’s constitutional mandate to produce and 
disseminate health statistics, and another demonstration of the Foundation’s immense power within 
global health (see also Boerma, Mathers, & Abou-Zahr, 2010). Saving face, the WHO revised their own 
global estimates, confirming the lower total and the downward trend (WHO, 2010). But many were 
concerned that the challenge to WHO’s statistical authority had further damaged the scientific credibility 
of maternal mortality data. ‘Do people really believe the information?’ asked one epidemiologist, before 
answering her own question: ‘Everybody knows. Everybody has concerns about maternal mortality’.
The ‘other’ indicators
An unintended, but significant, effect of measurement for global accountability and competition has 
been to divert attention from basic epidemiological monitoring data and actual measurement of mater-
nal mortality for national and sub-national problem solving. The push to monitor progress towards 
global goals, notably the MDGs, has, for example, imposed pressure on governments to demonstrate 
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success in ways that, as Yamin and Boulanger (2014, p. 113) observe, has provided incentives to invest in 
‘ever more sophisticated modelling and analysis based on poor data, while national health information 
systems have languished. This is unfortunate since many experts agree that it is well-functioning health 
information systems that can best mitigate the various technical and political problems with maternal 
mortality estimates and play a vital role in planning and monitoring public health programmes that 
can respond quickly to local epidemiological profiles.
Many of the leading measurement experts we interviewed reflected self-critically on such effects, 
which they had observed across the countries in which they conduct research. They admitted, for 
instance, that much of their measurement work may serve global accountability needs and even push 
countries to act to improve maternal health, but does too little to address the underlying problem of 
poor national-level capacity to measure and analyse maternal mortality. One informant commented 
that, ‘it is a tragic paradox that in Africa and other low-income countries there are no real data, despite 
the fact that that’s where the world’s great majority of the burden of disease lies’. Several privately 
suggested that the money and effort spent on refining maternal mortality measurement techniques 
would have been more judiciously spent on helping countries set up proper health information sys-
tems, including vital registration, census, and routine administrative data systems at national, district 
or facility levels. As maternal health experts have themselves argued, nineteenth century maternal 
mortality declines in Western Europe benefitted greatly from localised measurement and monitoring 
groups for developing effective and targeted initiatives (Béhague & Storeng, 2013).
Even those who had been involved in designing and modifying global survey techniques were 
self-critical about the drive for ever more sophisticated, frequent and large-scale surveys to produce 
mortality estimates. Several of our interlocutors explained that even if they could reveal the precise 
magnitude of maternal mortality, this would be of limited value in informing debates about how to 
improve maternal health. As a prominent American measurement specialist with more than three 
decades of experience explained:
I just learnt that the DHS (Demographic Health Survey) is going to spend like a zillion dollars in Pakistan to interview, 
what was it, 90,000 extra households. I don’t see the point of that … You go into Pakistan and spend how many 
million dollars and do this extra thing and … just to tell us again that women are dying … Of course they’re dying 
in Pakistan, there’s no bloody health system! If you come out of this study and you have a MMR of 750 or of 600, 
what are the differences in implications? None. Doesn’t tell you a thing. It’s high. We know it’s high.
This comment resonates with the view that the MMR may not actually be the most relevant indicator 
for assessing country-level progress and certainly not for informing country-level policy and planning. 
As another American maternal health epidemiologist said, ‘I think we should be looking at other kinds 
of indicators. Not forgetting maternal mortality, but not going all the fifty thousand yards to making 
that the real end…or state of the art indicator’. In effect, she was revisiting arguments first made in the 
1990s that process indicators – quantitative indicators of the availability, access to and quality of different 
healthcare services – may be better suited to assess specific countries’ progress towards the realisation 
of maternal health, even if there are still measurement problems associated with these indicators (cf. 
Yamin & Boulanger, 2014). ‘I’m not sure it’s maternal mortality we ought to be measuring,’ a leading 
UK-based epidemiologist pondered, and suggested the field should pay more attention to ‘trends 
in skilled attendance, trends in C-sections amongst the poor, which I think is a very good indicator.’ 
Unlike the MMR, process indicators like C-section coverage can often be disaggregated according to 
geographic and socio-economic variables, and can thereby be used to ensure equitable implemen-
tation of services. Such indicators, therefore, arguably respond better to country-level policy-makers 
and health planners’ need for context-specific data. Another advantage of process indicators, experts 
explained, is that they are often either available from existing recording systems at health facilities or 
incorporated into routine health information systems, and are thus cheaper and simpler to collect than 
maternal mortality data (cf. Goodburn, 2002). The epidemiologist cited above claimed that the safe 
motherhood field could do well to advocate more strongly for monitoring of service coverage data, 
rather than outcome data, even at the global level, as the Child Survival movement has done.
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Others returned to the concerns first expressed in the early 1990s that the focus on mortality data 
is too narrow. They drew attention to the ‘neglected agenda’ of maternal morbidity – delivery-related 
problems like anaemia, maternal depression, fistula and genital and uterine prolapse – estimated to 
be 20 times more frequent than maternal mortality (Hardee, Gay, & Blanc, 2012; WHO, 2004). A main 
argument for these informants was that donors and governments should consider morbidity data in 
priority setting, because when combined with mortality data, morbidity data help to show that preg-
nancy-related causes are ‘a leading contributor to the burden of disease among women’ (Koblinsky, 
Chowdhury, Moran, & Ronsmans, 2012, p. 124). Crucially, maternal health experts have noted that clinical 
interventions designed to reduce the MMR by targeting severe obstetric emergencies, the direct causes 
of maternal mortality, may have little if any impact on acute or chronic morbidity, which may require 
other treatment options, including surgical repair of fistulas and medical management of anaemia. 
Judging the success of maternal health efforts in terms of the MMR alone therefore leaves open the 
possibility of ‘meeting the target’ of MMR reduction, but ‘missing the goal’ of improving maternal health.
While many prominent measurement experts have thus, in various ways, tried to push for a more 
diverse evidence-base that includes an array of indicators, an impediment to this agenda is that, as we 
were often told, in the present climate only ‘hard’ indicators of the number of lives saved truly influence 
donors or enable governments to gain visibility on the global scene. A senior British epidemiologist 
put it bluntly:
That’s the only way you get the attention of the Bank and the big people … If you just go and say, ‘well, we changed 
a bit of behaviour’ they say ‘thank you’. But if you can actually say, ‘we’re hitting the Millennium Development Goal,’ 
then it hugely raises you up the agenda.
Discussion
Anthropologist Susan Erikson has argued that while indicators allegedly operate in the world as cred-
ible, apolitical and authoritative (Erikson, 2015, p. 1157), they are rarely neutral and are, instead, both 
value-laden and often, as Vincanne Adams puts it, quite ‘messy’ (Adams, 2016a, p. 59). Making numbers 
appear authoritative therefore requires hard work (Harper, 2006). Our findings support the observation 
that increasingly such work is about making ‘global’ data appear robust, requiring a high degree of 
“arithmetic gymnastics’ to make countries look metrically comparable (Adams, 2016b, p. 32). Indeed, 
in the history of maternal mortality measurement, scientific practice and measurement techniques are 
increasingly geared towards the data needs of donors that prioritise cost-effective logics rather than 
the data needs of national governments, and as such can be thought of in terms of ‘micropractices of 
neoliberalism’ (Adams, 2016a). Demands for evidence of the ‘number of lives saved’ as the product of 
return-on-investment help to explain the trend towards highly sophisticated statistical models and sur-
vey techniques to estimate maternal mortality at the partial expense of longer term investments national 
civil registration systems capable of measuring maternal deaths and other basic public health statistics.
At the start of the SMI, scientists were adamant that indirect estimation of maternal mortality was 
only an interim measure to be used until countries developed national health information systems 
capable of measuring maternal mortality. In reality, indirect modelling techniques have instead replaced 
routine information systems as the primary source of data on maternal mortality today. Experts justify 
research on indirect estimation techniques by claiming that such techniques produce data needed for 
‘tracking progress towards the development goals and monitoring and evaluating the effectiveness 
of programmes,’ and to respond to ‘international concern with accountability and rational resource 
allocation’ (Merdad et al., 2013). But questions are rarely asked about whose accountability is at stake 
and whose data needs are being met.
While we have focused on the impact on global scientific practice, the effects of such global prac-
tices of course become real when they manifest in local contexts. Scholars are starting to delineate the 
ambivalent effects that the current obsession with numerical targets has on the health programmes 
and governance processes at the national and local levels, including how they breed simplification and 
abstraction that distort programmatic practice (Hodžić, 2013; Oni-Orisan, 2016; Wendland, 2016; Yamin 
CRITICAL PUBLIC HEALTH  173
& Boulanger, 2014). Claire Wendland’s ethnographic work on maternal mortality in Malawi elegantly 
describes how technical challenges of producing data distort and ignore the local realities of deliver-
ies and maternal deaths, and how the numbers become mobilised as claims of success for individual 
political gain by Malawi’s former president and others (Wendland, 2016). Svea Closser’s (2011) study 
of the global Polio Eradication Initiative’s work in Pakistan analyses how officials created a culture of 
optimism by devaluing negative evidence. This intended and unintended manipulation of the num-
bers was designed to convince donors to continue funding the project, but prevented constructive 
analysis of the project’s problems. Similarly, in a powerful critique of the well-intentioned Norway–
India Partnership intended to accelerate progress on maternal and child survival, Sidsel Roalkvam and 
Desmond McNeill (2016) ask whether global initiatives to finance maternal and child health change the 
direction of accountability, with national governments becoming accountable upwards to donors for 
achieving specified numerical targets, rather than downwards to their citizens. They suggest that the 
blending within global public health of neoliberal ideology and a shared moral purpose of maximising 
the number of lives saved is deeply depoliticising, distracting attention from the configurations of power 
that shape the policy space of nation states (Roalkvam & McNeill, 2016, p. 69).
Measurement experts are not blind to such unintended effects; in fact, they generate considerable 
unease and debate within the measurement community. For example, while experts recognise that 
global estimates can persuade policy-makers to act, they can also undermine trust. WHO statisticians 
Carla AbouZahr and Ties Boerma (2005, p. 581) have argued, for instance, that when global agencies and 
academics use modelling to fill in missing data elements, ‘countries perceive this as an externally driven 
process, designed to meet donor needs and of little relevance to country action’. According to Sakiko 
Fukuda-Parr and colleagues (2014, p. 10), ‘indicators which depend upon global estimation exercises 
are poorly adapted to fostering national ownership and participation of the people who are the most 
affected by development programming’. At the heart of the dispute is a deep-seated concern that debates 
about whether global maternal mortality has improved or not can be a distraction from more important 
debates about the maternal health situation in particular countries, and crucially, how to improve it.
The fact that such debates rarely surface in public spheres reflects that it is difficult to challenge 
donors’ demands for ‘global’ data, especially because they are rooted in a business-oriented ethos that 
co-exists with stated commitment to public health values like the imperative to save lives. While donors 
have undoubtedly skewed measurement work away from national needs, they also support some major 
initiatives to improve national health information systems.
An example can be seen in the 50 million dollar grant the Gates Foundations provided in 2005 to form 
the Health Metrics Network in Geneva, a global health initiative that, until its closure in 2013, aimed to 
‘provide coherent and coordinated reform and strengthening of country health information systems’ 
(AbouZahr & Boerma, 2005, p. 583). Through health information assessments and support to more than 
70 countries, it intended to redress the lack of an overall vision of a comprehensive health information 
system that had hampered previous international efforts. Despite such good intentions, critics like 
Susan Erikson (2012, p. 375) have denounced the network as a ‘Gates-by-proxy institute’ whose claims 
to have strengthened national health systems in countries, like Sierra Leone, are ‘a myth’. An enduring 
paradox is that the very donors who committed to joint funding and development of national health 
information systems through initiatives like the Health Metrics Network also encourage bureaucratic 
expansion at the country level. For instance, they impose heavy reporting requirements (Taylor & Harper, 
2014) and support and implement their own data collection platforms and independent bodies for 
global monitoring (Storeng, 2014). Donors often support such initiatives due to concerns about the 
quality of data individual countries report, but doing so also paradoxically undermines national health 
information system strengthening.
Conclusion
In a commentary on academics’ role in the production of health indicators, Christopher Murray and Alan 
Lopez (2010, p. 210) – themselves world-renowned statisticians – write about a maternal health advocate 
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who called for scientists to be ‘locked in a room until they agree on one set of numbers’. This anecdote 
resonates with our informants’ stories about the pressure they felt from the broader safe motherhood 
community to support a coherent story about global mortality decline. Murray and Lopez go on to 
argue that such ‘artificial consensus’ about health statistics is fundamentally misguided because, they 
claim, policy-makers are sophisticated enough to understand that data on levels and trends are to some 
extent uncertain and are only to be used as rough guides. But their call for academics to exercise their 
responsibility to be open about statistical uncertainty contradicts many academics’ own experience 
that policy-makers either ‘don’t understand confidence intervals,’ or use uncertainty as an excuse to 
put their money elsewhere.
It also discounts just how deeply enmeshed academics have become within the prevailing power 
structures of global health governance. Maternal health research is to a large extent funded by global 
donors, including the Gates Foundation, which is well known for not welcoming open critique (Harman, 
2016), and academic livelihoods are dependent on sustained donor interest in maternal health. As we 
have shown elsewhere, those who continue to conduct research using intensive, historical, case-study 
methods that make effective use of trend data – once a mainstay of epidemiological research – now 
consider this an agenda that they must do ‘on the side’, almost as a form of indirect subversion of global 
mortality-based demands (Béhague & Storeng, 2013). Academic researchers may feel unease about 
their limited responsiveness to national data needs, but as David McCoy and others have argued, they 
work within an academic culture in which they lack the inclination, incentives and sometimes skills to 
conduct the sort of research that developing countries need (McCoy, Mwansambo, Costello, & Khan, 
2008, p. 1056). This partly explains why, 30 years after the first global maternal mortality estimates 
were produced, most MMRs continue to be based on a combination of data sources from surveys and 
mathematical modelling, while empirical measurement of actual maternal deaths remains scarce and 
measurement experts continue to question whether anybody trusts the data.
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